The RISE Study utilises longitudinal, semi-structured interviews to explore the experiences of people recently diagnosed with HIV in Australia, including life after diagnosis. To date, 28 people living with HIV have taken part in interviews, with over three-quarters having completed a follow-up interview. Issues including sex and HIV prevention prior to diagnosis, the clinical diagnosis experience, access to and use of HIV clinical care and peer support services, disclosure, sex, relationships, and impacts of COVID-19 are explored.
This report summarises data on the prescription and distribution of hepatitis C treatments and provides insight into the initial phase of the roll-out of DAA therapy in Australia.
This project used semi-structured interviews to explore the experiences of 24 overseas-born gay and bisexual men (GBM) recently diagnosed with HIV. In recent years, HIV notifications among this sub-population of GBM have increased. To respond effectively, focused attention is needed on the practices and beliefs of this sub-population. The objective of this project was to characterise the key factors and barriers contributing to new HIV diagnoses among this group.
The NSW Aboriginal Sexual and Reproductive Health (SRH) Program was a NSW Ministry of Health initiative which aimed to increase Aboriginal youth’s (aged 12–19 years) access to sexual and reproductive health programs through health promotion initiatives delivered by Aboriginal Sexual and Reproductive health workers based in seven Aboriginal Community Controlled Health Services (ACCHSs) and one Local Health District across NSW.
A reorientation of the original Flux (Following Lives Undergoing Change) Study, this report summarises baseline data collected from 913 gay and bisexual men (GBM) during April 2020 on the impacts of COVID-19 and physical distancing measures. We reported findings on sexual behaviours, use of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), drug use, mental health, testing for COVID-19 and social connectedness among GBM in Australia in the early stages of the pandemic.
Australia has been a world leader in research and surveillance documenting the impact of control programs for cervical cancer. C4 Partners include many investigators who have been collecting, analysing, and reporting key epidemiological information about the occurrence of cervical cancer and its precursors. The resources of C4 and its partner organisations have been used in consultation with key stakeholders to deliver this comprehensive report.
The Gaps Project Report synthesises multiple data sources to identify emerging HIV prevention gaps in various subpopulations of gay, bisexual, and other men who have sex with men (GBMSM) in Australia between 2009–2018. This includes HIV diagnoses data from the National HIV Registry, clinical data from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmissible Infections (ACCESS), and behavioural data from the Gay Community Periodic Surveys (GCPS).
Australia is aiming to eliminate hepatitis C as a public health threat by 2030. This elimination goal is in line with global targets set by the World Health Organization (WHO) and targets included in Australia’s National Hepatitis C Strategy 2018–2022.
Prepared by Burnet Institute and the Kirby Institute, this report brings together national data sources to assess Australia’s progress towards eliminating hepatitis C. Some data were not included due to unavailability at the time of reporting; future reports will provide the most comprehensive picture possible.
This report provides an overview of data HIV diagnoses in heterosexual people, Aboriginal and Torres Strait Islander people, and people who inject drugs in NSW during the NSW HIV Strategy 2016-2020, with analyses based on data available between 2013 and 2019.
This report provides a detailed overview of trends in HIV diagnoses and HIV prevention indicators in gay, bisexual and other men who have sex with men (GBMSM) during the NSW HIV Strategy 2016-2020, with analyses based on data available to the end of 2019.